Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Approval of prospectus

16 Aug 2011 14:04

RNS Number : 4635M
J.P. Morgan Private Equity Ltd
16 August 2011
 



 

 

 

Publication of Prospectus

J.P. Morgan Private Equity Ltd

16 August 2011

 

J.P. MORGAN PRIVATE EQUITY LIMITED (LSE:JPEL.L) ANNOUNCESUKLA Approval OF PROSPECTUS

 

GUERNSEY, 16 AUGUST 2011

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") announces that the Company's prospectus dated 16 August 2011 (the "Prospectus") has been approved by the UK Listing Authority:

 

The Prospectus, dated 16 August 2011, relates to the proposed issue of Issue of 44,727,053 US$ Equity Shares and 30,410,753 2017 Zero Dividend Preference Shares (together the "Placing Shares") in connection with the acquisition of a portfolio of middle-market co-investments from the SPL Funds and application for the admission to listing on the premium and standard segments of the Official List of the UK Listing Authority (as appropriate) and to trading on the Main Market of the London Stock Exchange of the Placing Shares

 

To view the prospectus, please click on the "Investor Information" and "Shareholder Documents" tabs on the Company's website (www.jpelonline.com).

 

Copies of the following documents are available for inspection at the offices of Herbert Smith LLP, Exchange House, Primrose Street, London EC2A 2HS and at the registered office of the Company during normal business hours of any Business Day until the date of Admission:

- the Memorandum and Articles of Incorporation of the Company;

- the audited reports and accounts for the years to 30 June 2008, 30 June 2009 and 30 June 2010;

- the unaudited interim reports and financial statements for the periods from 30 June 2010 to 30 June 2011; and

- the Prospectus.

 

In addition, copies of the Prospectus are available, for inspection only, from the National Storage Mechanism (http://www.hemscott.com/nsm.do).

 

 

ENQUIRIES

 

J.P. Morgan Private Equity Limited 

Troy Duncan: Tel (Direct): +44 207 742 3032 (troy.duncan@jpmorgan.com)

Gregory Getschow: Tel (Direct): +1 212 648 1151 (gregrory.getschow@jpmorgan.com)

Rosemary DeRise: Tel (Direct): +1 212 648 2980 (rosemary.derise@jpmorgan.com)

Samantha Ladd: Tel (Direct): +1 212 648 2982 (samantha.ladd@jpmorgan.com)

 

Peregrine Communications

Anthony Payne: Tel (Direct): +44 203 178 6869 (anthony.payne@peregrinecommunications.com)

 

Liberum Capital Limited (Sponsor to the Company and Broker to the Placing)

Steve Pearce / Tom Fyson / Christopher Britton: Tel (Direct): +44 (0)20 3100 2000

 

* * *

 

DISCLAIMER

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS IN SUCH JURISDICTION

 

This announcement, which has been made by J.P. Morgan Private Equity Limited and the information contained herein is not for release publication or distribution, directly or indirectly, in whole or in part in or into the United States, Australia, Canada or Japan or any other jurisdiction where to do so would constitute a violation of applicable laws in such jurisdiction. This announcement does not constitute or form part of an offer to sell, purchase, exchange or subscribe for any securities or the solicitation of such an offer to or from any person including any US person (as defined in Regulation S under the Securities Act, 'US Person') or person in the United States of America or any other jurisdiction. The Company has not been and will not be registered under the United States Investment Company Act of 1940, as amended (the 'Investment Company Act') and investors will not be entitled to the benefit of that Act. The securities referred to in this announcement have not been and will not be registered under the United States Securities Act 1933, as amended (the 'Securities Act'), and may not be offered or sold or otherwise transferred within the United States or to, or for the account or benefit of US Persons. Securities may not be offered or sold in the United States absent registration or an exemption from registration. The securities referred to in the Prospectus are being offered and sold only to non-US persons outside the United States.

 

This announcement is an advertisement and not a prospectus and does not constitute or form part of any offer, solicitation or invitation to purchase or subscribe for any securities in any jurisdiction. Investors must not subscribe for any securities referred to in this announcement except on the basis of the information contained in the Prospectus.

 

This communication is directed only at (i) persons outside the United Kingdom, or (ii) persons having professional experience in matters relating to investments who fall within the definition of 'investment professionals' in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 or (iii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. Any investment or investment activity to which this communication relates is only available to and will only be engaged in with such persons and persons within the United Kingdom who receive this communication (other than persons falling within (ii) and (iii) above) should not rely on or act upon this communication.

 

The release, publication or distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law. Persons to whom this announcement is made available should therefore inform themselves about and observe any such restrictions. No action has been taken by the Company that would permit the offer or sale of any securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Any failure to comply with any such restrictions may constitute a violation of the laws of such jurisdictions.

 

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIEADPKFEDFEFF
Date   Source Headline
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.